<DOC>
	<DOCNO>NCT01010035</DOCNO>
	<brief_summary>The diabetic dyslipidemia one important risk factor development coronary artery disease . The low density lipoprotein ( LDL ) -like nanoemulsions use study clearance cholesteryl ester free cholesterol intravascular patient advance coronary artery disease show high removal free cholesterol high deposit vases patient . The aim study analyze plasma kinetics form cholesterol ( free ad esterify ) type 2 diabetes patient without previous history cardiovascular disease .</brief_summary>
	<brief_title>Cholesterol Metabolism Lipid Transfer Diabetes</brief_title>
	<detailed_description>Hypercholesterolemia typical type 2 diabetes mellitus dyslipidemia , alteration LDL may occur relate atherogenesis.Cholesterol exist two main form organism : free cholesterol esterify cholesterol . An artificial model study two form cholesterol use LDL-like nanoemulsion doubly label 14C-cholesteryl ester 3H- cholesterol . This nanoemulsion make without protein intravascular compartment able acquires apolipoproteins others lipoprotein , apos A 's , C 's E. This model allow u use nanoemulsion particle probe study lipoproteins receptor bind cholesterol esterification process .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>without previous cardiovascular disease arterial hypertension , use antihypertensive drug must well control systolic Blood pressure level &lt; 130mmHg diastolic &lt; 85mmHg . total cholesterol &lt; 6 mmol/L LDL cholesterol &lt; 4 mmol/L use drug statin , fibrates , glucocorticoid , thiazolidinediones nephropathy presence microalbuminuria ( ratio microalbuminuria/creatinin &gt; 30 ug/mg ) serum creatinin 98umol/L woman 115 umol/L man retinopathy neuropathy presence chronic disease : heart failure , chronic obstructive pulmonary disease , inflammatory disease cancer</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>dyslipidemia</keyword>
	<keyword>kinetics</keyword>
</DOC>